RCUS
Arcus Biosciences, Inc.Data: 2026-09-11
Quick Stats
Sep 11, 202642.1
AI Score
HOLD3.54
Volume Ratio
Oct 27, 2026
Next Earnings
15
+ve Days (30d)
15
-ve Days (30d)
RCUS Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
RCUS Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
RCUS Options - Sort by Max open Interest (near term)
12th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RCUS Daily Out of Money Options - Sort by Max open Interest (near term)
12th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RCUS Daily In the Money Options - Sort by Max open Interest (near term)
12th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RCUS Most Active Options by Volume(near term)
12th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RCUS Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
RCUS Stock Summary
Last updated Sep 11, 2026
RCUS is currently trading at $24.59, positioned below its 200-day moving average of $24.74, suggesting bearish momentum. The stock has a 52-week range of $11.3 to $31.735.
Technical Analysis: The 50-day moving average stands at $28.92, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 28.13, suggesting the stock is oversold and potentially undervalued.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.158, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates RCUS at 42.1/100 with a HOLD recommendation.
RCUS (Arcus Biosciences, Inc.) Indicators
Last updated Sep 11, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 28.13 |
| CMF (20) | -0.158 |
| ROC (10) | -19.614 |
| ADX (14) | 13.87 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.444 |
| AROONOSC (14) | -85.714 |
| WILLAMS %R (14) | -96.215 |
| MFI (14) | 18.398 |
RCUS Candlestick Patterns
Validated patterns fired in the last 10 sessions. Hit rate = how often price moved in the signal's direction within 5 trading days (backtest: 2.7M signals, 3,500 liquid stocks, Feb 2025–Sep 2026). Baseline: a random stock closes higher 5 days later 53% of the time. Click a row to see the candle on the chart.
| Date | Pattern | Signal | 5-Day Hit Rate | Edge vs Baseline | Sample |
|---|---|---|---|---|---|
| Aug 31 | Thrusting Line | Bearish | 50.0% | +3.0 pts | 9556 |
These are statistical tilts, not standalone trade setups. Only patterns with a measured edge are shown — roughly 50 of 60 textbook patterns showed no edge and are hidden.
Arcus Biosciences, Inc. is below both the 50 Day and 200 Day SMA which is considered Bearish.
RCUS Moving Averages Analysis
RCUS (Arcus Biosciences, Inc.) Simple Moving Averages
Moving Averages are last updated Sep 11, 2026
| Days | MA |
|---|---|
| 10 | 28.61 |
| 20 | 29.4 |
| 30 | 29.08 |
| 50 | 28.92 |
| 100 | 27.1 |
| 200 | 24.74 |
RCUS Fundamental Analysis
| P/E (Forward) | -- |
| P/E (Trailing) | -- |
| Market Cap ($) | 3.3 billion |
| Earnings/Share ($) | -3.62 |
| Net Profit Margin (%) | -- |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -3.5257 |
| EPS Estimate Next Year ($) | -3.34 |
| WallStreet Target Price ($) | 38.75 |
| Most Recent Quarter |
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.